US 12133840
Halogenated xanthene composition and method for treating hematologic cancers
granted A61KA61K31/21A61K31/352
Quick answer
US patent 12133840 (Halogenated xanthene composition and method for treating hematologic cancers) held by Provectus Pharmatech, Inc. expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Provectus Pharmatech, Inc.
- Grant date
- Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/21, A61K31/352, A61K31/365, A61K9/0019